| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/25/2013 | CN103328474A Salts and crystalline forms of an apoptosis-inducing agent |
| 09/25/2013 | CN103328473A Substituted azaindazole compounds |
| 09/25/2013 | CN103328463A Chromene derivatives and their analoga as wnt pathway antagonists |
| 09/25/2013 | CN103328461A Compositions and methods of using crystalline forms of wortmannin analogs |
| 09/25/2013 | CN103328447A Compounds as c-Met kinase inhibitors |
| 09/25/2013 | CN103328446A Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer |
| 09/25/2013 | CN103328008A Agents for clearing biomolecules from circulation |
| 09/25/2013 | CN103327997A Moesin modulators and uses thereof |
| 09/25/2013 | CN103327994A Combination therapy for prostate cancer using botanical compositions and bicalutamide |
| 09/25/2013 | CN103327983A Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracyclin chemotherapeutic agents |
| 09/25/2013 | CN103327978A Methods of treating liver fibrosis and pre-cirrhosis with epidermal growth factor receptor inhibitors |
| 09/25/2013 | CN103327977A Therapeutic or prophylactic agent for cachexia |
| 09/25/2013 | CN103327976A Preselection of subjects for therapeutic treatment based on hypoxic status |
| 09/25/2013 | CN103327975A Combinations comprising macitentan for the treatment of glioblastoma multiforme |
| 09/25/2013 | CN103320449A Allium chinensis lectin gene with anti-tumor activity and application of coding protein thereof |
| 09/25/2013 | CN103320445A DNA (deoxyribonucleic acid) aptamer GCA-5 capable of specifically identifying gastric cancer cells and application of DNA aptamer GCA-5 |
| 09/25/2013 | CN103320444A Antisense oligonucleotide for tiny RNA-21 seed sequence and application thereof |
| 09/25/2013 | CN103320440A SiRNA specifically inhibiting breast cancer MDA-MB-468 cell proliferation, and application thereof |
| 09/25/2013 | CN103320439A Small nucleic acid activator specifically enhancing miR-34a promoter transcriptional activity |
| 09/25/2013 | CN103320284A A cactus-shiitake health-care wine and a preparation method thereof |
| 09/25/2013 | CN103319619A Application of lachnum extracellular polysaccharide phosphorylated derivative and application thereof in preparation of antitumor drugs |
| 09/25/2013 | CN103319617A Method for extracting purple potato polysaccharide by utilizing ultrasonic wave synergistic with enzymatic method and application |
| 09/25/2013 | CN103319610A Novel recombinant fusion protein, preparation method and use thereof |
| 09/25/2013 | CN103319606A Liver targeted peptide-recombinant human endostatin fusion protein, and preparation method and application thereof |
| 09/25/2013 | CN103319605A Hepatic targeting peptide and angiogenesis inhibitor fusion protein as well as preparation method and application thereof |
| 09/25/2013 | CN103319599A Anti-human ErbB2 antibody-ansamitocin conjugate and applications thereof |
| 09/25/2013 | CN103319598A Insulin-like growth factor-1 receptor (IGF-1R) resistant antibody and coding genes and applications thereof |
| 09/25/2013 | CN103319597A Insulin-like growth factor-1 receptor (IGF-1R) resistant antibody and coding genes and applications thereof |
| 09/25/2013 | CN103319595A Preparation method and application of anti-human alpha fetoprotein (AFP) single-chain antibody and fusion antigen peptide |
| 09/25/2013 | CN103319589A Preparation method of bioactive peptide for inhibiting stomach cancer stem cell proliferation |
| 09/25/2013 | CN103319588A Method for extracting galectin-3 from ranid and preparation thereof |
| 09/25/2013 | CN103319567A Tripeptide compound and preparation method and applications thereof |
| 09/25/2013 | CN103319508A Cellular structural supramolecular compound with drug molecule serving as ligand and preparation method of cellular structural supramolecular compound |
| 09/25/2013 | CN103319497A Preparation method of natural product Hirtellanine B and derivatives thereof, and application of natural product Hirtellanine B and derivatives thereof in tumor treatment drug preparation |
| 09/25/2013 | CN103319485A 6-(beta-alkylnaphthy)mercaptopurine compound, and synthesis method and application thereof |
| 09/25/2013 | CN103319477A Organic selenium compounds based on 1,3,4-thiadiazole and 1,3,4-oxadiazole, as well as preparation method and application method thereof |
| 09/25/2013 | CN103319476A Kinase inhibitor |
| 09/25/2013 | CN103319470A Compound based on structure of Sant-75 |
| 09/25/2013 | CN103319468A Substituted spirobicyclic compounds, and application method and applications thereof |
| 09/25/2013 | CN103319456A Dihydropyridine compounds, and compositions, preparation methods and applications thereof |
| 09/25/2013 | CN103319438A 4-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivative and its preparation method and application |
| 09/25/2013 | CN103319436A Preparation, refining method and freeze-drying preparation of injection-grade acetazolamide sodium |
| 09/25/2013 | CN103319431A 2-mercaptoacetophenone-containing 1, 3, 4-oxadiazole derivative, its preparation method and antitumor activity |
| 09/25/2013 | CN103319404A Nitroxoline derivatives and use of the nitroxoline derivatives as angiogenesis inhibitors |
| 09/25/2013 | CN103319403A Tumor angiogenesis inhibitor jilintong, preparation method and uses thereof |
| 09/25/2013 | CN103319402A Diphenyl thiourea derivatives, preparation method and applications thereof |
| 09/25/2013 | CN103319371A Preparation method and application of N-substituted hydroxamic acid compound |
| 09/25/2013 | CN103319365A Isotretinoin amido derivative, preparation method thereof and applications thereof |
| 09/25/2013 | CN103316359A Application of long-chain non-coding RNA in preparation of non-small cell lung cancer treatment drugs |
| 09/25/2013 | CN103316356A Recombinant lentivirus vector preparation |
| 09/25/2013 | CN103316352A Graphene oxide nano-drug carrier and anti-tumor drug as well as preparation method of anti-tumor drug |
| 09/25/2013 | CN103316351A Electrostatic spinning complex loaded with two drugs |
| 09/25/2013 | CN103316344A EGFR-TKI compound for delaying or reversing drug-resistance in lung cancer treatment, and preparation thereof |
| 09/25/2013 | CN103316343A Application of biguanide based medicament in medicaments for delaying or reversing acquired drug-resistance of NSELC treated by EGFR-TKI |
| 09/25/2013 | CN103316341A Fullerene-nanogold composite material as well as preparation method and application thereof |
| 09/25/2013 | CN103316340A Gold nanocomposite particle having plasma photothermal/photodynamic therapy performance, and preparation method thereof |
| 09/25/2013 | CN103316325A Traditional Chinese medicine preparation for treating ovarian cyst |
| 09/25/2013 | CN103316301A Method for removing bitter taste of turmeric |
| 09/25/2013 | CN103316299A Chinese medicine composition for treating primary liver cancer |
| 09/25/2013 | CN103316271A Traditional Chinese medicinal composition and preparation method thereof |
| 09/25/2013 | CN103316249A Astragalus taxus chinensis capsule and preparing process thereof |
| 09/25/2013 | CN103316220A Active substance composition, preparation method therefor, preparations thereof, and applications thereof |
| 09/25/2013 | CN103316213A Qilianyisui detoxification particles and preparation method thereof |
| 09/25/2013 | CN103316200A Externally-used traditional Chinese medicine for treating malignant tumors of peritoneal cavity |
| 09/25/2013 | CN103316194A Dracaena cambodiana leaf superfine pure powder, preparation method therefor, and preparations thereof |
| 09/25/2013 | CN103316191A Natural medicine extract |
| 09/25/2013 | CN103316190A Natural pharmaceutical composition |
| 09/25/2013 | CN103316189A Natural pharmaceutical composition |
| 09/25/2013 | CN103316187A 中药提取物 Chinese medicine extract |
| 09/25/2013 | CN103316186A 中药组合物 Chinese medicine composition |
| 09/25/2013 | CN103316175A Traditional Chinese medicine powder, and preparation method and application thereof |
| 09/25/2013 | CN103316153A Natural pharmaceutical composition and preparation method thereof |
| 09/25/2013 | CN103316120A Applications of clausena excavata burm and extractive thereof |
| 09/25/2013 | CN103316119A Traditional Chinese medicine for treating leukemia |
| 09/25/2013 | CN103316115A Traditional Chinese medicinal composition and preparation method thereof |
| 09/25/2013 | CN103316113A Natural pharmaceutical composition |
| 09/25/2013 | CN103316112A Natural pharmaceutical composition |
| 09/25/2013 | CN103316099A Gynecologic inflammation treatment spray |
| 09/25/2013 | CN103316096A General flavone extract of seeds of nigella damascena l., nigella sativa l. or nigella glandulifera freyn et sint., and preparation method and use thereof |
| 09/25/2013 | CN103316089A Natural pharmaceutical composition |
| 09/25/2013 | CN103316088A Natural pharmaceutical composition |
| 09/25/2013 | CN103316080A Special traditional Chinese medicine essence for preventing and treating benign laryngeal tumors and extraction process thereof |
| 09/25/2013 | CN103316076A Esophageal cancer resisting traditional Chinese medicine essence and extraction process thereof |
| 09/25/2013 | CN103316065A Dandelion fluid decoction pieces and preparation method thereof |
| 09/25/2013 | CN103316062A Novel application of mulgedium tataricum |
| 09/25/2013 | CN103316061A Traditional Chinese medicinal mixture for treating cancer and preparation method thereof |
| 09/25/2013 | CN103316057A Soup for resisting cancer and senescence, and treating burn and scald, and preparation method thereof |
| 09/25/2013 | CN103316051A New functions and applications of trametes lactinea(Berk.)Pat. or extractives and trametenloic acid B |
| 09/25/2013 | CN103316050A Painless and surgery-free empirical formula for treating lymphoma and cyst as well as preparation method and application method thereof |
| 09/25/2013 | CN103316042A Composition capable of causing endoplasmic reticulum stress |
| 09/25/2013 | CN103316035A Use of sodium bicarbonate in preparation of medicines for treating cancer |
| 09/25/2013 | CN103316012A Application of Aspeverin in preparation of medicine for treating pancreas cancer |
| 09/25/2013 | CN103316011A Application of Aspeverin in preparation of medicine for treating skin cancer |
| 09/25/2013 | CN103316010A Application of Aspeverin in preparation of medicine for treating liver cancer |
| 09/25/2013 | CN103316009A Application of Aspeverin in preparation of medicine for treating cervical carcinoma |
| 09/25/2013 | CN103316008A Application of Aspeverin in preparation of medicine for treating rectal cancer |
| 09/25/2013 | CN103316006A Application of Myriberine A in preparation of medicine for treating lung cancer |
| 09/25/2013 | CN103316002A Application of compound in preparation of drug for treating breast cancer |
| 09/25/2013 | CN103315995A Use of alpha-hydroxy carbonyl compounds as reducing agents |
| 09/25/2013 | CN103315993A Application of dihydromyricetin in preparation of medicines for inhibiting adriamycin cardiotoxicity |